Investor Eventide Asset Management, Llc
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Eventide Asset Management, Llc . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Add This Fund
to your dashboard

Date Form Target Prev
Shares		 Current
Shares		 Change
(Percent)		 Ownership
(Percent)		 Change
(Percent)
2025-08-14 13G/A VYNE / VYNE Therapeutics Inc. 1,394,336 1,849,597
2025-08-14 13G/A EVH / Evolent Health, Inc. 6,077,191 4,086,852
2025-08-14 13G/A CLDX / Celldex Therapeutics, Inc. 3,332,005 1,356,186
2025-05-15 13G 10,118,517
2025-05-14 13G EVH / Evolent Health, Inc. 6,077,191
2025-05-14 13G/A ZNTL / Zentalis Pharmaceuticals, Inc. 0 0
2025-05-14 13G/A AURA / Aura Biosciences, Inc. 0 0
2025-05-13 13G/A ZNTL / Zentalis Pharmaceuticals, Inc. 4,475,054 0
2025-05-13 13G/A AURA / Aura Biosciences, Inc. 4,080,605 0
2025-04-23 13G/A INZY / Inozyme Pharma, Inc. 2,220,000 2,220,000
2025-02-14 13G/A ZNTL / Zentalis Pharmaceuticals, Inc. 7,090,108 4,475,054
2025-02-14 13G/A XMTR / Xometry, Inc. 4,418,664 3,151,897
2025-02-14 13G/A NKTR / Nektar Therapeutics 9,400,000 6,650,000
2025-02-14 13G/A MIRM / Mirum Pharmaceuticals, Inc. 3,445,363 2,606,938
2025-02-14 13G/A LXEO / Lexeo Therapeutics, Inc. 1,855,986 1,234,834
2025-02-14 13G/A INZY / Inozyme Pharma, Inc. 4,134,436 2,220,000
2025-02-14 13G/A AURA / Aura Biosciences, Inc. 5,802,682 4,080,605
2025-02-05 13G BBNX / Beta Bionics, Inc. 4,857,041
2024-11-14 13G/A XMTR / Xometry, Inc. 5,727,770 4,418,664
2024-11-14 13G/A MIRM / Mirum Pharmaceuticals, Inc. 2,693,581 3,445,363
2024-11-14 13G/A MRNS / Marinus Pharmaceuticals, Inc. 4,529,997 0
2024-11-14 13G/A LXEO / Lexeo Therapeutics, Inc. 2,192,211 1,855,986
2024-11-14 13G/A KRRO / Korro Bio, Inc. 546,325 391,166
2024-11-14 13G/A INZY / Inozyme Pharma, Inc. 3,179,837 4,134,436
2024-11-14 13G/A CLDX / Celldex Therapeutics, Inc. 3,630,013 3,332,005
2024-11-14 13G NKTR / Nektar Therapeutics 9,400,000
2024-11-06 13G/A ZNTL / Zentalis Pharmaceuticals, Inc. 11,559,975 7,090,108
2024-08-09 13G/A LXEO / Lexeo Therapeutics, Inc. 3,002,831 2,192,211
2024-02-14 13G/A MIRM / Mirum Pharmaceuticals, Inc. 2,057,000 2,693,581
2024-02-14 13G/A ANNX / Annexon, Inc. 3,626,508 0
2024-02-14 13G/A XMTR / Xometry, Inc. 5,730,339 5,727,770
2024-02-14 13G/A VECT / VectivBio Holding AG 3,405,644 0
2024-02-14 13G/A PRAX / Praxis Precision Medicines, Inc. 0
2024-02-14 13G/A MRNS / Marinus Pharmaceuticals, Inc. 3,150,000 4,529,997
2024-02-14 13G/A FRLN / Freeline Therapeutics Holdings plc - Depositary Receipt (Common Stock) 0
2024-02-14 13G/A COLL / Collegium Pharmaceutical, Inc. 2,629,593 2,630,478
2024-02-14 13G/A MASS / 908 Devices Inc. 2,230,665 1,430,995
2024-02-14 13G KRRO / Korro Bio, Inc. 546,325
2024-02-14 13G INZY / Inozyme Pharma, Inc. 3,179,837
2024-02-14 13G CLDX / Celldex Therapeutics, Inc. 3,630,013
2023-12-11 13G/A ZNTL / Zentalis Pharmaceuticals, Inc. 7,814,039 11,559,975
2023-12-11 13G/A AURA / Aura Biosciences, Inc. 2,251,368 5,802,682
2023-12-11 13G LXEO / Lexeo Therapeutics, Inc. 3,002,831
2023-11-13 13G VYNE / VYNE Therapeutics Inc. 1,394,336
2023-11-13 13G XMTR / Xometry, Inc. 5,730,339
2023-10-10 13G ZNTL / Zentalis Pharmaceuticals, Inc. 7,814,039
2023-02-14 13G/A VITL / Vital Farms, Inc. 2,950,000 0
2023-02-14 13G/A STRO / Sutro Biopharma, Inc. 2,708,975 0
2023-02-14 13G/A EPIX / ESSA Pharma Inc. 3,318,647 0
2023-02-14 13G/A ZYME / Zymeworks Inc. 2,819,135 0
2023-02-14 13G/A VECT / VectivBio Holding AG 2,339,044 3,405,644
2023-02-14 13G/A RXDX / Prometheus Biosciences Inc 3,742,507 1,032,938
2023-02-14 13G/A US35655L1070 / Freeline Therapeutics Holdings PLC 3,485,656 5,920,765
2023-02-14 13G/A COGT / Cogent Biosciences, Inc. 3,514,909 2,589,778
2023-02-14 13G/A ANNX / Annexon, Inc. 2,850,000 3,626,508
2023-02-14 13G/A PRAX / Praxis Precision Medicines, Inc. 3,810,599 3,518,062
2023-02-14 13G/A KNBE / KnowBe4 Inc - Class A 4,177,983 0
2023-02-14 13G MIRM / Mirum Pharmaceuticals, Inc. 2,057,000
2023-02-14 13G MRNS / Marinus Pharmaceuticals, Inc. 3,150,000
2023-02-14 13G AURA / Aura Biosciences, Inc. 2,251,368
2023-02-14 13G MASS / 908 Devices Inc. 2,230,665
2022-02-14 13G/A COLL / Collegium Pharmaceutical, Inc. 2,427,976 2,629,593
2022-02-14 13G/A VITL / Vital Farms, Inc. 2,053,232 2,950,000
2022-02-14 13G/A STRO / Sutro Biopharma, Inc. 2,370,975 2,708,975
2022-02-14 13G/A PRAX / Praxis Precision Medicines, Inc. 3,513,081 3,810,599
2022-02-14 13G/A PLRX / Pliant Therapeutics, Inc. 2,838,125 42,499
2022-02-14 13G/A KALV / KalVista Pharmaceuticals, Inc. 1,680,000 138,821
2022-02-14 13G/A KALA / KALA BIO, Inc. 3,450,000 0
2022-02-14 13G/A FRLN / Freeline Therapeutics Holdings plc - Depositary Receipt (Common Stock) 2,485,656 3,485,656
2022-02-14 13G/A EPIX / ESSA Pharma Inc. 2,335,168 3,318,647
2022-02-14 13G/A ETTX / Entasis Therapeutics Holdings Inc 879,541 590,602
2022-02-14 13G ZYME / Zymeworks Inc. 2,819,135
2022-02-14 13G/A ANNX / Annexon, Inc. 2,004,616 2,850,000
2022-02-14 13G VECT / VectivBio Holding AG 2,339,044
2022-02-14 13G RXDX / Prometheus Biosciences Inc 3,742,507
2022-02-14 13G COGT / Cogent Biosciences, Inc. 3,514,909
2022-02-10 13G KNBE / KnowBe4 Inc - Class A 4,177,983
2021-02-12 13G/A EPIX / ESSA Pharma Inc. 2,010,169 2,335,168
2021-02-12 13G/A MGTA / Magenta Therapeutics Inc 3,393,894 1,000,000
2021-02-12 13G/A NAUT / Nautilus Biotechnology, Inc. 800,000 0
2021-02-12 13G/A STML / Stemline Therapeutics, Inc. 4,160,608 0
2021-02-12 13G VITL / Vital Farms, Inc. 2,053,232
2021-02-12 13G PLRX / Pliant Therapeutics, Inc. 2,838,125
2021-02-12 13G PRAX / Praxis Precision Medicines, Inc. 3,513,081
2021-02-12 13G/A ZGNX / Zogenix Inc 2,841,300 0
2021-02-12 13G/A STRO / Sutro Biopharma, Inc. 1,244,895 2,370,975
2021-02-12 13G KALA / KALA BIO, Inc. 3,450,000
2021-02-12 13G 2,485,656
2021-02-12 13G US16706W1027 / Chiasma Inc 3,000,326
2021-02-12 13G ANNX / Annexon, Inc. 2,004,616
2020-02-04 13G/A 867328601 / Sunesis Pharmaceuticals, Inc. 2,265,455 0
2020-02-04 13G STML / Stemline Therapeutics, Inc. 4,160,608
2020-02-04 13G ZGNX / Zogenix Inc 2,841,300
2020-02-04 13G/A COLL / Collegium Pharmaceutical, Inc. 2,207,610 2,427,976
2020-02-04 13G/A EPIX / ESSA Pharma Inc. 2,010,168 2,010,169
2020-02-04 13G/A KALV / KalVista Pharmaceuticals, Inc. 900,000 1,680,000
2020-02-04 13G/A MGTA / Magenta Therapeutics Inc 2,650,808 3,393,894
2019-08-30 13G EPIX / ESSA Pharma Inc. 1,385,168 2,010,168
2019-07-15 13D/A EPIX / ESSA Pharma Inc. 1,385,970 1,385,168
2019-05-23 13D EPIX / ESSA Pharma Inc. 1,385,970 1,385,970
2019-02-13 13G MGTA / Magenta Therapeutics Inc 2,650,808
2019-02-13 13G ETTX / Entasis Therapeutics Holdings Inc 879,541
2019-02-13 13G NAUT / Nautilus Biotechnology, Inc. 800,000
2019-02-13 13G/A BBI / Brickell Biotech Inc 1,700,000 0
2019-02-13 13G/A EPIX / ESSA Pharma Inc. 27,719,410 1,385,970
2019-02-13 13G/A VCYT / Veracyte, Inc. 2,133,500 930,000
2019-02-13 13G STRO / Sutro Biopharma, Inc. 1,244,895
2019-02-13 13G/A KALV / KalVista Pharmaceuticals, Inc. 709,000 900,000
2019-02-13 13G/A COLL / Collegium Pharmaceutical, Inc. 2,207,610 2,207,610
2019-02-13 13G/A 867328601 / Sunesis Pharmaceuticals, Inc. 2,265,455 2,265,455
2019-02-13 13G/A TCON / TRACON Pharmaceuticals, Inc. 900,000 0
2018-03-09 13G/A EPIX / ESSA Pharma Inc. 2,719,410 27,719,410
2018-02-12 13G/A TCON / TRACON Pharmaceuticals, Inc. 865,526 900,000
2018-02-12 13G 867328601 / Sunesis Pharmaceuticals, Inc. 2,265,455
2018-02-12 13G KALV / KalVista Pharmaceuticals, Inc. 709,000
2018-02-12 13G/A EPIX / ESSA Pharma Inc. 2,719,410 2,719,410
2018-02-12 13G/A COLL / Collegium Pharmaceutical, Inc. 2,077,751 2,207,610
2018-02-12 13G/A CAFD / 8point3 Energy Partners LP 1,553,700 1,461,400
2018-02-12 13G BBI / Brickell Biotech Inc 1,700,000
2018-02-12 13G/A VCYT / Veracyte, Inc. 2,252,000 2,133,500
2017-02-13 13G COLL / Collegium Pharmaceutical, Inc. 1,401,001 2,077,751
2017-02-13 13G EPIX / ESSA Pharma Inc. 2,719,410
2017-02-13 13G ZSAN / Zosano Pharma Corp 888,300 272,000
2017-02-13 13G TCON / TRACON Pharmaceuticals, Inc. 865,526
2017-02-13 13G CAFD / 8point3 Energy Partners LP 1,124,200 1,553,700
2016-02-12 13G/A VCYT / Veracyte, Inc. 2,252,000
2016-02-12 13G COLL / Collegium Pharmaceutical, Inc. 1,401,001
2016-02-12 13G ZSAN / Zosano Pharma Corp 888,300
2016-02-12 13G CAFD / 8point3 Energy Partners LP 1,124,200
2015-02-13 13G VCYT / Veracyte, Inc. 1,384,100